<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Management of acute pain in opioid naïve adults in the ambulatory setting
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Management of acute pain in opioid naïve adults in the ambulatory setting
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Management of acute pain in opioid naïve adults in the ambulatory setting
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carlos A Pino, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sarah E Wakeman, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Scott G Weiner, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert Maniker, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marianna Crowley, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 19, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3666038489">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goals for acute pain management are to relieve suffering, facilitate function, and enhance recovery. The optimal strategy for acute pain control consists of multimodal therapy to increase efficacy, reduce side effects of therapy, and minimize the need for opioids. This topic will discuss multimodal analgesia based on the expected degree of pain for patients in the ambulatory setting.
        </p>
        <p>
         Treatment of acute pain for patients chronically using opioids and for inpatients after surgery is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/83726.html" rel="external">
          "Management of acute pain in the patient chronically using opioids for non-cancer pain"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2980648061">
         <span class="h1">
          GOALS AND PRINCIPLES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goal for acute pain control should not be zero pain, but rather a tolerable level of pain that allows physical and emotional function. Often this means balancing analgesia with achieving functional goals, while avoiding preventable complications.
        </p>
        <p>
         General principles include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Create an individualized plan for pain management based on the expected degree of pain and patient factors that may affect the plan
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Offer multimodal analgesia, adding opioids only as necessary
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Provide patient education
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adjust the pain management plan based on adequacy of pain relief and the occurrence of adverse events
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3784978569">
         <span class="h2">
          Use multimodal analgesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest a multimodal approach to analgesia for acute pain, with nonpharmacologic techniques, regional anesthesia techniques as appropriate, nonopioid analgesics, and opioids only as necessary. Multimodal analgesia involves the use of two or more agents that employ different mechanisms for pain management, thereby reducing overreliance on and adverse effects from a single class of agents, most importantly opioids.
        </p>
        <p class="headingAnchor" id="H1148481992">
         <span class="h2">
          Use opioids safely
         </span>
         <span class="headingEndMark">
          —
         </span>
         An overarching principle of acute pain management is to avoid excessive or prolonged use of opioids. Opioids are associated with short term side effects (eg, respiratory depression, sedation, nausea and vomiting, pruritus, urinary retention, constipation) and long term adverse effects (eg, tolerance, dependence, opioid induced hyperalgesia, withdrawal upon conclusion of therapy, opioid use disorder, and overdose). (See
         <a class="local">
          'The decision to prescribe opioids'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1364330662">
         <span class="h1">
          PATIENT EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient evaluation should include assessment of medical and psychological conditions, substance use disorder, pain treatment history, and long term medications, all of which may affect the plan for analgesia. These considerations are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults", section on 'Patient evaluation'
         </a>
         .)
        </p>
        <p>
         If opioids are considered, the Prescription Drug Monitoring Program (PDMP) database should be checked prior to prescribing. In the United States, all states have instituted PDMPs. Some states require, and others suggest, that clinicians check the PDMP database prior to prescribing opioids. Studies on the efficacy of PDMPs regarding opioid prescribing practice are limited and have found mixed results, however a general practice of checking PDMP prior to prescribing may be helpful in confirming other controlled substance prescriptions a patient is receiving [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15236.html" rel="external">
          "Prescription drug misuse: Epidemiology, prevention, identification, and management", section on 'Prescription monitoring programs'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1501617691">
         <span class="h1">
          PAIN TRAJECTORIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         For many patients, acute pain peaks at one to three days after injury or surgery and should be much less by seven days. However, the expected degree of pain and time course of resolution varies widely with both the type of injury or surgery and patient factors, including prior history of alcohol, drug, or opioid use; history of anxiety or depression; and patient age.
        </p>
        <p>
         As has been demonstrated for perioperative pain, the anatomic location, type of tissue damaged, and type of surgery affect the degree of pain. In general, procedures and injuries that involve bones and joints are more painful than those that involve soft tissue [
         <a href="#rid2">
          2-4
         </a>
         ]. In one prospective study involving approximately 5100 ambulatory surgical patients who received multimodal analgesia (ie,
         <a class="drug drug_general" data-topicid="9682" href="/z/d/drug information/9682.html" rel="external">
          naproxen
         </a>
         premedication, local anesthetic infiltration, or regional anesthesia as appropriate), the percent of patients with severe pain at 24 hours varied by the type of surgery [
         <a href="#rid5">
          5
         </a>
         ]. Patients who underwent microdiscectomy were most likely to have severe pain, followed by laparoscopic cholecystectomy, shoulder surgery, elbow/hand surgery, ankle procedures, inguinal hernia repair, and knee surgery.
        </p>
        <p>
         A number of studies have examined the degree of pain and/or the quantity of opioid required for pain relief after specific ambulatory surgical procedures [
         <a href="#rid2">
          2,5-9
         </a>
         ]. Generalizability may be limited, as most are single institution studies, and some do not report the use of non-opioid medications or analgesic techniques (eg, local anesthetic infiltration, peripheral nerve blocks).
        </p>
        <p>
         The
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmichigan-open.org%2Fprescribing-recommendations%2F&amp;token=gJB%2FBNQdLa5V4q3LoI%2BYkvqQFpkWl6FkbQtxyuRs7PByVdrcpXDdNEPKBs29PN0uAyOGYjU9DjE%2FlG84H%2BIhgw%3D%3D&amp;TOPIC_ID=108806" target="_blank">
          Michigan OPEN
         </a>
         website provides evidence based opioid prescribing recommendations for over 70 common adult and pediatric surgical procedures, with citations for supporting literature, and based on data collected across the state of Michigan.
        </p>
        <p class="headingAnchor" id="H3737191247">
         <span class="h1">
          BASIC MEASURES FOR ALL PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         For all patients, regardless of the expected degree of pain, acute pain management should include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonpharmacologic techniques (eg, ice or heat, elevation, immobilization, rest, relaxation techniques or meditation) as appropriate
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Local or regional anesthesia/analgesia techniques when appropriate, and
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We suggest
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         and nonsteroidal anti-inflammatory drugs (NSAIDs) unless there are contraindications, rather than either drug alone.
        </p>
        <p>
        </p>
        <p>
         Local and regional anesthesia techniques are most commonly used for patients who undergo surgical procedures, often to provide analgesia after discharge from the hospital or day surgery unit. (See
         <a class="medical medical_review" href="/z/d/html/397.html" rel="external">
          "Overview of peripheral nerve blocks", section on 'Use of nerve blocks'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H647565245">
         <span class="h1">
          STRATEGY BASED ON EXPECTED DEGREE AND DURATION OF PAIN
         </span>
         <span class="headingEndMark">
          —
         </span>
         After evaluating for risk factors that may predispose a patient to greater than expected acute pain, it is reasonable to create a management strategy based on the expected or existing degree of pain and the likely trajectory, recognizing that
         <strong>
         </strong>
         the degree of pain may not fit into discrete categories of mild, moderate, or severe pain.
        </p>
        <p>
         Clinicians should avoid basing decisions regarding analgesia on the basis of race. Studies have demonstrated racial disparities in both acute and chronic pain management. As an example, a systematic review of studies examining acute pain treatment in emergency departments found that Black patients were significantly less likely to receive analgesia than White patients [
         <a href="#rid10">
          10
         </a>
         ]. Implicit bias and false beliefs about biological differences in pain tolerance may contribute to ongoing racial disparities [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         The components of pain control strategies are discussed here. The use of specific analgesics is discussed below. (See
         <a class="local">
          'Analgesics'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H863637970">
         <span class="h2">
          Expected mild pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mild pain can be expected after sprains, nonspecific low back pain, dental extraction, superficial surgical procedures, and headaches. Opioids should not be required to adequately treat minor pain.
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          Acetaminophen
         </a>
         and/or nonsteroidal anti-inflammatory drugs (NSAIDs) or cyclooxygenase (COX)-2 inhibitors usually provide adequate pain relief in the treatment of mild to moderate pain [
         <a href="#rid12">
          12-14
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1056053749">
         <span class="h2">
          Expected moderate pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most laparoscopic and minimally invasive surgery, most soft tissue surgeries, and non-compound and non-comminuted fractures result in moderate pain. For some patients, regional anesthesia techniques (eg, single injection or continuous peripheral nerve blocks) may be appropriate. In addition to regularly scheduled non-opioid analgesics, opioids may be necessary for some of these patients. In most cases, a three-day prescription of short-acting opioid should suffice. (See
         <a class="local">
          'Opioids for moderate pain'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H597374698">
         <span class="h2">
          Expected severe pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Severe pain can be expected after major non-laparoscopic surgery, maxillofacial surgery, total joint replacement, compound fractures, and long bone fracture prior to definitive stabilization. In addition to non-opioid analgesics, regional anesthesia techniques should be used when possible. Opioids are typically necessary. A prescription for up to seven days of higher dose opioid may be required to adequately manage pain. If follow-up can be arranged prior to seven days, the prescription should be written for the time period up until the follow-up appointment. Initiation of extended release/long-acting opioids should generally be avoided even with expected severe acute pain. If these agents are considered (eg, new onset of severe cancer-related pain), we suggest involving a specialist in pain medicine. (See
         <a class="local">
          'Opioids for severe pain'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1481035469">
         <span class="h1">
          ANALGESICS
         </span>
        </p>
        <p class="headingAnchor" id="H3283372054">
         <span class="h2">
          Nonopioid analgesics
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest using both
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         and nonsteroidal anti-inflammatory drugs (NSAIDs) as part of multimodal analgesia for patients without contraindications, rather than either drug alone. We suggest taking acetaminophen and NSAIDs on a scheduled basis rather than "as needed," with the rationale that pain control may be more sustained than if taken as needed. However, there is very little literature comparing these dosing strategies [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
         NSAIDs may be more effective than
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         for some types of pain (eg, dental pain [
         <a href="#rid16">
          16,17
         </a>
         ]), and a combination of an NSAID with acetaminophen may be more effective than either type of drug alone for various types of acute pain [
         <a href="#rid16">
          16,18,19
         </a>
         ].
        </p>
        <p>
         Use of nonopioid analgesics for acute pain is discussed in detail separately. Doses are shown in a table  (
         <a class="graphic graphic_table graphicRef139393" href="/z/d/graphic/139393.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/133187.html" rel="external">
          "Nonopioid pharmacotherapy for acute pain in adults"
         </a>
         .)
        </p>
        <p>
         Topical analgesics (eg, topical
         <a class="drug drug_general" data-topicid="9348" href="/z/d/drug information/9348.html" rel="external">
          diclofenac
         </a>
         and/or
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         ) may be beneficial for some patients with localized pain (eg, sprain or muscle strain), particularly for patients who are at increased risk of side effects from systemic analgesics. Topical NSAIDs penetrate local tissues in the area of application but have limited systemic absorption and therefore fewer side effects and drug interactions. (See
         <a class="medical medical_review" href="/z/d/html/133187.html" rel="external">
          "Nonopioid pharmacotherapy for acute pain in adults", section on 'Choice of NSAID'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/133187.html" rel="external">
          "Nonopioid pharmacotherapy for acute pain in adults", section on 'Topical lidocaine'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3844797732">
         <span class="h2">
          Opioids
         </span>
        </p>
        <p class="headingAnchor" id="H3382969709">
         <span class="h3">
          The decision to prescribe opioids
         </span>
         <span class="headingEndMark">
          —
         </span>
         The decision to prescribe opioids for acute pain should always involve a risk benefit analysis, balancing the need for analgesia against opioid side effects (eg, constipation, nausea, drowsiness, dizziness), and risks of respiratory depression, dependence, long term use, and use disorder. We reserve opioids for patients in whom other therapies are either contraindicated or likely to be incompletely effective on their own, and we evaluate the patient’s risk of opioid-related harm. When deemed necessary for acute pain, we prescribe opioids at the lowest effective dose and for the shortest duration possible.
        </p>
        <p>
         Factors that increase the risk of opioid misuse or long term use are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/120966.html" rel="external">
          "Risk of long term opioid use and misuse after prescription of opioids for pain"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H86040722">
         <span class="h3">
          Avoid excessive prescription
         </span>
         <span class="headingEndMark">
          —
         </span>
         Every effort should be made to avoid prescribing more opioid than necessary. Leftover pills are available for diversion and inappropriate use. Among those who engage in nonmedical prescription opioid use, over 70 percent obtain opioids without a prescription, and 40 to 50 percent receive the drug from family members or friends who have leftover pills [
         <a href="#rid20">
          20-22
         </a>
         ]. Overprescription can also lead to overconsumption [
         <a href="#rid23">
          23
         </a>
         ], which can lead to very high doses (usually without functional benefit), which is associated with an increased risk of overdose.
        </p>
        <p>
         Multiple studies have shown that excessive opioid medications are routinely prescribed for all types of surgical procedures, as well as after emergency department visits for painful conditions [
         <a href="#rid24">
          24,25
         </a>
         ], and most patients save leftover pills [
         <a href="#rid2">
          2,4,6,7,9,26-36
         </a>
         ]. As a result, large amounts of opioid tablets are available for non-medical use.
        </p>
        <p>
         A number of institutions have implemented protocols, educational programs, or feedback systems designed to reduce unnecessary opioid prescription for acute pain [
         <a href="#rid7">
          7,37-41
         </a>
         ]. In general, such efforts result in reduced number of prescribed pills, without an increase in refills or reduced patient satisfaction [
         <a href="#rid42">
          42
         </a>
         ]. As an example, a retrospective study of over 600 opioid naïve patients who underwent laparoscopic cholecystectomy, thyroidectomy, or inguinal hernia repair compared patient reported outcomes in patients who participated in an opioid sparing postoperative pathway versus patients who received standard care [
         <a href="#rid37">
          37
         </a>
         ]. Patients in the opioid sparing pathway used fewer opioid pills, reported less pain, and had similar satisfaction. In the opioid sparing pathway, patients received a median of four
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         tablets (5 mg) postoperatively, compared with a median of 20 tablets for patients who received standard care. Forty percent of patients in the opioid sparing pathway received no postoperative opioid prescription. Conclusions from this study are limited by lack of data on intraoperative analgesic strategies, the retrospective nature of the study, and the limited range of surgical procedures studies.
        </p>
        <p class="headingAnchor" id="H1747458108">
         <span class="h3">
          Choice of opioid
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the United States, the most commonly prescribed opioids for acute pain include
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         ,
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          hydrocodone
         </a>
         , and to a lesser extent,
         <a class="drug drug_general" data-topicid="9291" href="/z/d/drug information/9291.html" rel="external">
          codeine
         </a>
         and
         <a class="drug drug_general" data-topicid="10010" href="/z/d/drug information/10010.html" rel="external">
          tramadol
         </a>
         [
         <a href="#rid43">
          43,44
         </a>
         ].
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          Morphine
         </a>
         immediate release (IR) and
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         are other options.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Short versus long-acting opioids
         </strong>
         –
         <strong>
         </strong>
         Consistent with the guidelines from the Centers for Disease Control and Prevention (CDC) and other professional and governmental organizations, we suggest that IR opioids should be used for acute pain management in opioid naïve patients in the ambulatory setting, rather than long-acting or extended release opioids. IR opioids reach peak effect within 45 to 60 minutes, compared with three to four hours for extended release (ie, slow release or prolonged release) opioids. Thus, rapid titration to effect is safer and easier with IR drugs.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Unintentional overdose may be more likely if opioid therapy is initiated with long-acting opioids. In one cohort study involving initiation of opioid therapy in approximately 840,000 opioid naïve patients over 10 years, unintentional overdose in the first two weeks was five times more likely in patients who received long-acting opioids, compared with those who took short-acting opioids [
         <a href="#rid45">
          45
         </a>
         ]. Generalizability may be limited by the patient population (chronic pain, veterans) and conclusions are limited by the retrospective nature of the study and limited information on patient substance use disorder, psychiatric illness, or comorbidities.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Choice of drug
         </strong>
         –
         <strong>
         </strong>
         The typical opioid prescription for acute pain consists of
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         5 mg pills, or the equivalent dose of
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          hydrocodone
         </a>
         (approximately 5 mg) and such doses appear in most opioid prescribing guidelines. There is little evidence to support the systematic choice of one of the commonly used opioids over another, either in terms of efficacy, tolerability, or risk of misuse. Factors that may influence the choice or dose of opioid include the patient’s age, hepatic or kidney impairment, genetic polymorphisms (eg, for
         <a class="drug drug_general" data-topicid="9291" href="/z/d/drug information/9291.html" rel="external">
          codeine
         </a>
         or
         <a class="drug drug_general" data-topicid="10010" href="/z/d/drug information/10010.html" rel="external">
          tramadol
         </a>
         ), and interactions with other drugs the patient is taking  (
         <a class="graphic graphic_table graphicRef142435" href="/z/d/graphic/142435.html" rel="external">
          table 2
         </a>
         ). We avoid the use of codeine and tramadol as first line agents because of wide interpatient variability in metabolism, unreliable analgesia, and related incidences of adverse events. Tramadol has mixed pharmacologic effects and is a weak mu opioid receptor agonist. It is associated with similar adverse effects as other opioids, including risks of misuse and physiologic dependence as well as unreliable metabolism due to its dependence on unpredictable P450 hepatic conversion to an active metabolite. In an insurance database study that included over 350,000 patients who received a prescription of opioids after surgery, tramadol was associated with a higher risk of prolonged opioid use, compared with other short-acting opioids [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Considerations when choosing among
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         ,
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          hydrocodone
         </a>
         , and
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         IR include the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph utd-adt-cnt utd-adt-pathwys">
          •
         </span>
         <strong>
          Potency
         </strong>
         –
         <strong>
         </strong>
         A number of state, federal, and professional guidelines for opioid prescription base the recommended or allowed doses on
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         milligram equivalents (MME). However, there are no standard methods for opioid conversion, and available online calculators and published conversion tables provide variable and inconsistent conversion ratios [
         <a href="#rid47">
          47,48
         </a>
         ]. In addition, there is wide variability among clinicians when converting opioid doses, whether they use printed or online opioid conversion tables [
         <a href="#rid49">
          49
         </a>
         ]. Therefore, whereas it may be necessary to calculate MME for regulatory reasons, morphine equivalents should only be used clinically as a general guide for starting doses, with modification based on patient factors, age, prior opioid history, concomitant drug therapy, and available preparations  (
         <a class="graphic graphic_table graphicRef111216" href="/z/d/graphic/111216.html" rel="external">
          table 3
         </a>
         ).
         <span class="utd-adt-cnt utd-adt-pathwys utd-content-120884">
          (Related Pathway(s):
          <a class="utd-content-120884" href="/pathway/120884?topicRef=108806&amp;source=see_link">
           Morphine milligram equivalent calculator for adults with chronic non-cancer pain
          </a>
          .)
         </span>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         When considering dose equivalence, it is preferable to underestimate the opioid dose with a watchful approach that includes incremental dose escalation, rather than risking overestimation of dosage. Starting doses for opioids are discussed below and appear in a table  (
         <a class="graphic graphic_table graphicRef142435" href="/z/d/graphic/142435.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Generally accepted conversion ratios may not reflect actual clinical effect. As examples:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Despite the fact that
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          hydrocodone
         </a>
         is thought to be approximately two thirds as potent as
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         , oxycodone 5 mg or hydrocodone 5 mg, each in combination with
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         or
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         , may be similarly effective when administered for a variety of painful conditions [
         <a href="#rid50">
          50-52
         </a>
         ]. One retrospective study of over 6840 surgical patients from 64 hospitals in Michigan compared outcomes in patients who were prescribed 5 mg tablets of hydrocodone or oxycodone [
         <a href="#rid53">
          53
         </a>
         ]. Patients who were prescribed hydrocodone took slightly more pills (mean 7 versus 6 pills) than those who were prescribed oxycodone. Pain scores, patient satisfaction, and opioid refills were similar in the two groups.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Some conversion tables show the potency of
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         IR to be approximately half that of
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         . However, in one randomized crossover study in volunteers who took 10 or 20 mg oxycodone versus 30 or 60 mg morphine IR, the potency ratio between morphine and oxycodone was 3:1 [
         <a href="#rid54">
          54
         </a>
         ]. Opioid effect was determined by the degree of miosis. The lowest dose tablet available for morphine IR is 15 mg, which was as efficacious as oxycodone 5 mg by the results of this study.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Misuse potential
         </strong>
         –
         <strong>
         </strong>
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          Oxycodone
         </a>
         may have greater likability (positive subjective effects) than
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          hydrocodone
         </a>
         and
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         , though the evidence supporting this is not conclusive. In a review of nine small randomized trials that compared the relative likeability of various opioids, oxycodone was associated with greater likeability and/or misuse potential than hydrocodone or morphine, which were similar [
         <a href="#rid55">
          55
         </a>
         ]. However, the included studies used various routes of opioid administration, different methods for outcome assessment, and all study subjects were either current or former opioid users. In the randomized trial described above, there was no difference in likeability between oxycodone and morphine IR [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Risk of overdose
         </strong>
         –
         <strong>
         </strong>
         Evidence comparing the risk of overdose with the commonly prescribed opioids is limited. In a retrospective database study of opioid related adverse events in the year after initial opioid prescription of
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         or
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          hydrocodone
         </a>
         , for patients who took either drug along with
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         , oxycodone was associated with a lower risk of long term opioid use, but a higher risk of overdose [
         <a href="#rid56">
          56
         </a>
         ]. The risk of overdose in patients who took
         <a class="drug drug_general" data-topicid="9730" href="/z/d/drug information/9730.html" rel="external">
          oxycodone-acetaminophen
         </a>
         was 0.27 percent, versus 0.24 percent in patients who took
         <a class="drug drug_general" data-topicid="8531" href="/z/d/drug information/8531.html" rel="external">
          hydrocodone-acetaminophen
         </a>
         . Risk of overdose was higher in patients who took oxycodone monotherapy, at 0.44 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Available preparations
         </strong>
         –
         <strong>
         </strong>
         Other opioids may be preferred rather than
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          hydrocodone
         </a>
         for patients who take regularly scheduled
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         and NSAIDS as part of multimodal pain control, because the others are available as sole drugs. In the United States, IR hydrocodone is only available in combination with acetaminophen or
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         . Therefore, the maximum recommended doses of the non-opioid component may complicate and limit administration of hydrocodone when those medications are also taken separately.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The lowest dose available tablet of
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         IR is 15 mg, such that a starting dose of 7.5 mg requires splitting the tablet or using the oral solution.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2575684606">
         <span class="h3">
          Opioid dose and duration
         </span>
         <span class="headingEndMark">
          —
         </span>
         When possible, medical centers should create procedure specific guidelines for opioid prescription based on patient utilization data [
         <a href="#rid57">
          57
         </a>
         ]. Lacking such data, online tools (eg,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmichigan-open.org%2Fprescribing-recommendations%2F&amp;token=gJB%2FBNQdLa5V4q3LoI%2BYkvqQFpkWl6FkbQtxyuRs7PByVdrcpXDdNEPKBs29PN0uAyOGYjU9DjE%2FlG84H%2BIhgw%3D%3D&amp;TOPIC_ID=108806" target="_blank">
          Opioid Prescribing Recommendations for Surgery
         </a>
         from
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmichigan-open.org%2Fprescribing-recommendations%2F&amp;token=gJB%2FBNQdLa5V4q3LoI%2BYkvqQFpkWl6FkbQtxyuRs7PByVdrcpXDdNEPKBs29PN0uAyOGYjU9DjE%2FlG84H%2BIhgw%3D%3D&amp;TOPIC_ID=108806" target="_blank">
          Michigan OPEN
         </a>
         ) can be used to guide post procedure prescribing, based on current data. The following is a reasonable strategy for opioid prescription based on the expected level of pain.
        </p>
        <p class="headingAnchor" id="H539789305">
         <span class="h4">
          Opioids for moderate pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who are expected to have moderate pain (eg, most laparoscopic and minimally invasive surgery, most soft tissue surgeries, and non-compound and non-comminuted fractures), the following are reasonable prescriptions for patients without risk factors that require modification of the choice or dose of drug. For older adult or frail patients, lower dose opioid may be sufficient and safer (eg,
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         2.5 mg).
        </p>
        <p>
         Note that the number of pills in parentheses refer to the number of pills to be dispensed for the entire prescription. Patients should be directed to take one tablet as needed, no more frequently than every three to four hours and usually three doses per day will suffice. This will translate into 3 to 4 pills per day of one of the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          Oxycodone
         </a>
         5 mg (ie, 12 tablets) or
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          Hydrocodone
         </a>
         5 mg (ie, 12 tablets) (available only with
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         or
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         ) (see
         <a class="local">
          'Choice of opioid'
         </a>
         above) or
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          Hydromorphone
         </a>
         2 mg (ie, 12 tablets)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          Morphine
         </a>
         IR 7.5 mg (ie, 6 tablets, to be split)
        </p>
        <p>
        </p>
        <p>
         We avoid prescribing
         <a class="drug drug_general" data-topicid="10010" href="/z/d/drug information/10010.html" rel="external">
          tramadol
         </a>
         because of wide interpatient variability in metabolism, unreliable analgesia, and related incidences of adverse events. However, if tramadol is used because the options listed above are problematic, it is usually prescribed as three to four 50 mg pills per day (eg, 12 tablets).
        </p>
        <p>
         For pain that is expected to last beyond three days, a five-day prescription (eg, 20 tablets of
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         5 mg or
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         2 mg) may be reasonable [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H179179008">
         <span class="h4">
          Opioids for severe pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients expected to have severe pain (eg, after major non-laparoscopic surgery, maxillofacial surgery, total joint replacement, compound fractures, and long bone fracture prior to definitive stabilization), a prescription for up to seven days of higher dose opioid may be required after discharge to adequately manage pain. For patients who are inpatients after surgery or injury, their opioid usage in the 24 hours prior to discharge may be used to guide outpatient prescription. As an example, for a patient who uses
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         10 mg every 4 hours in the 24 hours prior to discharge, the prescription should be written for 10 to 12 tablets of oxycodone 5 mg for use on day 1 to 2 after discharge, with enough additional tablets for an expected taper over the five- to seven-day prescription. Patients should be provided with clear guidance about the expectations for tapering and should be instructed to return for follow up if severe pain persists prior to expected follow up.
        </p>
        <p>
         If follow-up can be arranged prior to seven days, the prescription should be written for the time period up until the follow-up appointment. Since electronic prescribing for opioids is now available in most of the United States, there is less need to write excessive prescriptions "just in case," as the clinician can generate an additional prescription without the need for the patient to visit the clinic.
        </p>
        <p>
         Patients should be instructed to take one to two tablets every three to four hours as needed for severe pain. This guidance should translate into an average of 4 to 6 pills per day of the entire prescription of one of the following opioids, for patients without risk factors that require modification of the choice or dose of drug.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          Oxycodone
         </a>
         5 mg or
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">
          Hydrocodone
         </a>
         5 mg (available only with
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         or
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         ) (see
         <a class="local">
          'Choice of opioid'
         </a>
         above) or
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          Hydromorphone
         </a>
         2 mg
        </p>
        <p>
        </p>
        <p>
         For
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         IR 15 mg, the prescription should include 2 to 3 pills per day of the prescription. Patients should be instructed to take ½ to 1 tablet every three to four hours as needed for severe pain.
        </p>
        <p class="headingAnchor" id="H1437484483">
         <span class="h3">
          Discuss naloxone
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinicians should discuss the availability of
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         with patients and caregivers. In 2020 the US Food and Drug Administration (FDA) required that labels for all opioids include the recommendation that care providers discuss availability of naloxone with all patients who are prescribed opioids, and specifically consider co-prescribing naloxone for patients who take benzodiazepines or other central nervous system depressants, who have a history of prior opioid overdose, or who have household members at risk for accidental ingestion [
         <a href="#rid59">
          59
         </a>
         ]. Some states (eg, California) require prescribers to offer a prescription of naloxone if the daily opioid dose is &gt;90 MME, the opioid is prescribed with a benzodiazepine, or there is an increased risk for opioid overdose. Additionally, some states require opioid prescribers to provide education on overdose prevention, including use of naloxone.
        </p>
        <p>
         As of 2023,
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         is available in the United States over the counter, without a prescription.
        </p>
        <p class="headingAnchor" id="H2648763418">
         <span class="h1">
          PATIENT EDUCATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinician should discuss the goals for pain relief, reasonable options for pain management, and specific instructions on taking, tapering and stopping, storing, and disposing of medication. This is particularly important for patients who receive opioids. Some states mandate that the patient sign a consent prior to starting a long-acting opioid, while others (eg, Vermont) require a signed consent prior to starting any opioid.
        </p>
        <p class="headingAnchor" id="H2981097841">
         <span class="h2">
          Expectation for pain relief
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinicians should discuss the goals for pain relief with patients, and if appropriate, their care providers, including reasonable expectations for pain relief. The goal should not be zero pain, but mild, tolerable pain that allows the patient to function.
        </p>
        <p class="headingAnchor" id="H454766372">
         <span class="h2">
          Risks and side effects of opioid therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who are prescribed opioids, clinicians should discuss the risks of physiologic dependence, addiction, and overdose, side effects of opioids, and the importance of additional or alternative treatment to reduce the required dose. An example of
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fdrugoverdose%2Fpdf%2FAHA-Patient-Opioid-Factsheet-a.pdf&amp;token=%2FwkpIlDqOw5RFNVxeROaQybqqYq%2BjGxqJNe7bq2I6wvCmxM%2BPdM6nQQNXlQjvOkz0jQpiTi3dA%2BhpuDWewDx%2BA0GHQpZJdktlCDGlL6WYy0%3D&amp;TOPIC_ID=108806" target="_blank">
          patient instructions
         </a>
         on prescription opioids is available on the Centers for Disease Control and Prevention (CDC) website [
         <a href="#rid60">
          60
         </a>
         ]. The American College of Surgeons provides patient oriented
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.facs.org%2Fmedia%2F5nlfjo3c%2Fsafe_pain_control_adult.pdf&amp;token=JfjrrVBtzEewy8fdMaXAsrDIB0pyc3xtjKXr%2FD6OKZRvV3EBKhHv%2BBM4K7Z2%2BPLC4I3Dl7NolDPoBfm%2B9el46V4BZukQ9z3YRlu34eDv4Zg%3D&amp;TOPIC_ID=108806" target="_blank">
          guidance for safe pain control
         </a>
         on their website.
        </p>
        <p>
         Opioids are associated with nausea and vomiting, dizziness, drowsiness, and a dose-dependent incidence of constipation [
         <a href="#rid61">
          61
         </a>
         ]. For patients who are prone to constipation, older patients, and those who are prescribed more than a few days of opioids, we co-prescribe a laxative and stool softener  (
         <a class="graphic graphic_table graphicRef59746" href="/z/d/graphic/59746.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H695043453">
         <span class="h2">
          How to take medication
         </span>
         <span class="headingEndMark">
          —
         </span>
         The patient should receive specific instructions on the way to take opioid and non-opioid medication, including how to decrease or stop the medication. Patients should be informed that opioids should only be used when non-opioid pain medications/treatments fail to provide adequate pain relief, and opioids should be tapered quickly while continuing to take nonopioid analgesics. Patients should also be told that unless their health care provider advises otherwise, they should avoid taking benzodiazepines along with opioids.
        </p>
        <p>
         <strong>
          Opioid taper and discontinuation
         </strong>
         –
         <strong>
         </strong>
         Acute pain often peaks at one to three days after injury or surgery, and should be much less by seven days (see
         <a class="local">
          'Pain trajectories'
         </a>
         above). Thus, patients for severe pain may require frequent and higher opioid doses (1 or 2 tablets every three to four hours) for the first postoperative day, and progressively less frequent and lower doses over the following days.
        </p>
        <p>
         It is important to give patients specific instructions for tapering opioids. Patients should be instructed to take opioids as needed, while continuing nonopioid analgesics. As acute pain improves patients should be advised to reduce the individual doses and space out the dosing interval. As an example, a patient taking one pill every six hours for the first three days may be able to decrease to every eight hours on day 4, every twelve hours on day 5, just once in day 6 and then be done.
        </p>
        <p class="headingAnchor" id="H1778135333">
         <span class="h2">
          Safe storage and disposal
         </span>
         <span class="headingEndMark">
          —
         </span>
         Opioids should be stored by patients in secure locations and excess pills should be disposed of properly, to minimize the risk of diversion and inappropriate use. Patients should receive specific instruction on both issues. Most studies have reported that patients do not routinely receive instruction on storage and disposal of opioids [
         <a href="#rid27">
          27,62
         </a>
         ], and most keep surplus medication at home for later use [
         <a href="#rid8">
          8,26,28
         </a>
         ]. Two randomized trials found that patients who were provided with disposal kits after receiving a postoperative opioid prescription were more likely to dispose of leftover opioids than those who did not receive these materials [
         <a href="#rid63">
          63,64
         </a>
         ]. In 2023 the United States Food and Drug Administration (FDA) announced a new requirement that manufacturers of opioids must make available postage paid mail back envelopes at pharmacies that dispense opioids in outpatient settings [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
         The US FDA has issued guidelines for disposal of opioid medication. When possible, the US FDA recommends taking excess opioids to US Drug Enforcement Agency authorized take back locations, which are often pharmacies or police stations. Alternatively, opioids can either be combined with an unpalatable substance (eg, dirt or kitty litter) and placed in a sealed container in household trash, or flushed down toilet [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1085811338">
         <span class="h1">
          ADJUSTING THE PLAN AS NECESSARY
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is critical to frequently reassess patients, especially those reporting inadequate pain control after guidelines are followed. For patients taking opioids, avoid reflexively increasing the dose, and instead consider other options of multimodal medications, nonpharmacologic treatment such as physical therapy, and providing patient reassurance.
        </p>
        <p>
         It is also important to evaluate for symptoms of opioid withdrawal, as tolerance can develop quickly after starting opioids and a patient’s perception of pain or side effects may actually be due to withdrawal from the prescribed opioids.
        </p>
        <p>
         Some patients who complain of pain despite what is thought to be adequate analgesics should be reassessed for possible complications of the injury, condition, or surgery that was performed.
        </p>
        <p class="headingAnchor" id="H1694652088">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118304.html" rel="external">
          "Society guideline links: Acute pain management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2911413240">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Goal for pain relief
         </strong>
         –
         <strong>
         </strong>
         The goal for pain control should be a tolerable level of pain that allows physical and emotional function. (See
         <a class="local">
          'Goals and principles'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patient evaluation
         </strong>
         –
         <strong>
         </strong>
         Patients should be evaluated for medical and psychological conditions, substance use disorder, pain treatment history, and medications that may make pain control more difficult or influence the choice of analgesics. (See
         <a class="local">
          'Patient evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If opioids are considered, the Prescription Drug Monitoring Program (PDMP) database should be checked.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Basic measures for all patients
         </strong>
         –
         <strong>
         </strong>
         Acute pain management should include the following, regardless of the degree of pain (see
         <a class="local">
          'Basic measures for all patients'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nonpharmacologic strategies (eg, ice or heat, elevation, immobilization, rest, relaxation techniques or meditation) as appropriate
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Local or regional anesthesia/analgesia techniques when appropriate
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We suggest
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         and nonsteroidal anti-inflammatory drugs (NSAIDs) unless there are contraindications, and together rather than either drug alone (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Strategies based on the degree of pain
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mild pain
         </strong>
         – Mild pain should be expected after sprains, dental extraction, superficial surgical procedures, and headaches. Basic strategies described above should suffice and opioids should not be necessary. (See
         <a class="local">
          'Expected mild pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Moderate pain
         </strong>
         –
         <strong>
         </strong>
         Opioids may be necessary in addition to basic strategies. Regional anesthesia/analgesia techniques may be appropriate. (See
         <a class="local">
          'Expected moderate pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Severe pain
         </strong>
         –
         <strong>
         </strong>
         Regional anesthesia/analgesia techniques should be used when possible. Opioids are usually necessary. (See
         <a class="local">
          'Expected severe pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonopioid analgesics
         </strong>
         –
         <strong>
         </strong>
         We suggest taking
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         and
         <strong>
         </strong>
         NSAIDs on a regular basis, rather than as needed (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ), for more even and sustained analgesia  (
         <a class="graphic graphic_table graphicRef139393" href="/z/d/graphic/139393.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Nonopioid analgesics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Opioids
         </strong>
         –
         <strong>
         </strong>
         We prescribe opioids only when necessary, after evaluating the patient’s risk of opioid related harm, and at the lowest effective dose for the shortest duration possible. (See
         <a class="local">
          'Opioids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We suggest prescribing short acting (immediate release) opioids rather than long acting opioids for acute pain in opioid naïve patients (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). This is consistent with guidelines from the Centers for Disease Control and Prevention (CDC) and other professional and governmental organizations. Rapid titration to effect is easier with immediate release opioids, and the risk of unintentional overdose may be greater with long-acting opioids  (
         <a class="graphic graphic_table graphicRef142435" href="/z/d/graphic/142435.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Choice of opioid'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          Naloxone
         </a>
         should be discussed with any patient who is prescribed opioids. (See
         <a class="local">
          'Discuss naloxone'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients should be instructed to take opioids as needed, every three to four hours.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Acute pain peaks at one to three days after surgery or injury, and decreases thereafter. Patients should receive specific instructions on tapering opioids by decreasing the dose and increasing the dosing interval over days as pain subsides, while continuing to take nonopioid analgesics. (See
         <a class="local">
          'How to take medication'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prescription details are discussed above. (See
         <a class="local">
          'Opioid dose and duration'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patient education
         </strong>
         – Expectations for pain relief and how to take medication should be discussed with all patients. For patients who take opioids, the discussion should include the risks and benefits, instructions on tapering and discontinuation of opioids, and safe storage and disposal of opioids. (See
         <a class="local">
          'Patient education'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Wilson MN, Hayden JA, Rhodes E, et al. Effectiveness of Prescription Monitoring Programs in Reducing Opioid Prescribing, Dispensing, and Use Outcomes: A Systematic Review. J Pain 2019; 20:1383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim N, Matzon JL, Abboudi J, et al. A Prospective Evaluation of Opioid Utilization After Upper-Extremity Surgical Procedures: Identifying Consumption Patterns and Determining Prescribing Guidelines. J Bone Joint Surg Am 2016; 98:e89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waljee JF, Zhong L, Hou H, et al. The Use of Opioid Analgesics following Common Upper Extremity Surgical Procedures: A National, Population-Based Study. Plast Reconstr Surg 2016; 137:355e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodgers J, Cunningham K, Fitzgerald K, Finnerty E. Opioid consumption following outpatient upper extremity surgery. J Hand Surg Am 2012; 37:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGrath B, Elgendy H, Chung F, et al. Thirty percent of patients have moderate to severe pain 24 hr after ambulatory surgery: a survey of 5,703 patients. Can J Anaesth 2004; 51:886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hill MV, McMahon ML, Stucke RS, Barth RJ Jr. Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures. Ann Surg 2017; 265:709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hill MV, Stucke RS, McMahon ML, et al. An Educational Intervention Decreases Opioid Prescribing After General Surgical Operations. Ann Surg 2017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris K, Curtis J, Larsen B, et al. Opioid pain medication use after dermatologic surgery: a prospective observational study of 212 dermatologic surgery patients. JAMA Dermatol 2013; 149:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maughan BC, Hersh EV, Shofer FS, et al. Unused opioid analgesics and drug disposal following outpatient dental surgery: A randomized controlled trial. Drug Alcohol Depend 2016; 168:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee P, Le Saux M, Siegel R, et al. Racial and ethnic disparities in the management of acute pain in US emergency departments: Meta-analysis and systematic review. Am J Emerg Med 2019; 37:1770.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoffman KM, Trawalter S, Axt JR, Oliver MN. Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proc Natl Acad Sci U S A 2016; 113:4296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones P, Lamdin R, Dalziel SR. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database Syst Rev 2020; 8:CD007789.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bijur PE, Friedman BW, Irizarry E, et al. A Randomized Trial Comparing the Efficacy of Five Oral Analgesics for Treatment of Acute Musculoskeletal Extremity Pain in the Emergency Department. Ann Emerg Med 2021; 77:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cramer JD, Barnett ML, Anne S, et al. Nonopioid, Multimodal Analgesia as First-line Therapy After Otolaryngology Operations: Primer on Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Otolaryngol Head Neck Surg 2021; 164:712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pillai Riddell RR, Craig KD. Time-contingent schedules for postoperative analgesia: a review of the literature. J Pain 2003; 4:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bailey E, Worthington HV, van Wijk A, et al. Ibuprofen and/or paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom teeth. Cochrane Database Syst Rev 2013; :CD004624.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith EA, Marshall JG, Selph SS, et al. Nonsteroidal Anti-inflammatory Drugs for Managing Postoperative Endodontic Pain in Patients Who Present with Preoperative Pain: A Systematic Review and Meta-analysis. J Endod 2017; 43:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merry AF, Gibbs RD, Edwards J, et al. Combined acetaminophen and ibuprofen for pain relief after oral surgery in adults: a randomized controlled trial. Br J Anaesth 2010; 104:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg 2010; 110:1170.
          </a>
         </li>
         <li class="breakAll">
          Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings. Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586; Findings, Substance Abuse and Mental Health Services Administration, Rockville, MD 2010.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manchikanti L, Helm S 2nd, Fellows B, et al. Opioid epidemic in the United States. Pain Physician 2012; 15:ES9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han B, Compton WM, Blanco C, et al. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Ann Intern Med 2017; 167:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farley KX, Anastasio AT, Kumar A, et al. Association Between Quantity of Opioids Prescribed After Surgery or Preoperative Opioid Use Education With Opioid Consumption. JAMA 2019; 321:2465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnett ML, Olenksi AR, Jena AB. Opioid Prescribing by Emergency Physicians and Risk of Long-Term Use. N Engl J Med 2017; 376:1896.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy DM, Kim HS, Hur SI, et al. Patient-Reported Opioid Pill Consumption After an ED Visit: How Many Pills Are People Using? Pain Med 2021; 22:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartels K, Mayes LM, Dingmann C, et al. Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery. PLoS One 2016; 11:e0147972.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silvestre J, Reddy A, de la Cruz M, et al. Frequency of unsafe storage, use, and disposal practices of opioids among cancer patients presenting to the emergency department. Palliat Support Care 2016; :1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tanabe P, Paice JA, Stancati J, Fleming M. How do emergency department patients store and dispose of opioids after discharge? A pilot study. J Emerg Nurs 2012; 38:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bateman BT, Cole NM, Maeda A, et al. Patterns of Opioid Prescription and Use After Cesarean Delivery. Obstet Gynecol 2017; 130:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osmundson SS, Schornack LA, Grasch JL, et al. Postdischarge Opioid Use After Cesarean Delivery. Obstet Gynecol 2017; 130:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiels CA, Anderson SS, Ubl DS, et al. Wide Variation and Overprescription of Opioids After Elective Surgery. Ann Surg 2017; 266:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monitto CL, Hsu A, Gao S, et al. Opioid Prescribing for the Treatment of Acute Pain in Children on Hospital Discharge. Anesth Analg 2017; 125:2113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujii MH, Hodges AC, Russell RL, et al. Post-Discharge Opioid Prescribing and Use after Common Surgical Procedure. J Am Coll Surg 2018; 226:1004.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan WH, Yu J, Feaman S, et al. Opioid Medication Use in the Surgical Patient: An Assessment of Prescribing Patterns and Use. J Am Coll Surg 2018; 227:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howard R, Fry B, Gunaseelan V, et al. Association of Opioid Prescribing With Opioid Consumption After Surgery in Michigan. JAMA Surg 2019; 154:e184234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ladha KS, Neuman MD, Broms G, et al. Opioid Prescribing After Surgery in the United States, Canada, and Sweden. JAMA Netw Open 2019; 2:e1910734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson M, Hallway A, Brummett C, et al. Patient-Reported Outcomes After Opioid-Sparing Surgery Compared With Standard of Care. JAMA Surg 2021; 156:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tamboli M, Mariano ER, Gustafson KE, et al. A Multidisciplinary Patient-Specific Opioid Prescribing and Tapering Protocol Is Associated with a Decrease in Total Opioid Dose Prescribed for Six Weeks After Total Hip Arthroplasty. Pain Med 2020; 21:1474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanek JJ, Renslow MA, Kalliainen LK. The effect of an educational program on opioid prescription patterns in hand surgery: a quality improvement program. J Hand Surg Am 2015; 40:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fox TR, Li J, Stevens S, Tippie T. A performance improvement prescribing guideline reduces opioid prescriptions for emergency department dental pain patients. Ann Emerg Med 2013; 62:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Findlay BL, Britton CJ, Glasgow AE, et al. Long-term Success With Diminished Opioid Prescribing After Implementation of Standardized Postoperative Opioid Prescribing Guidelines: An Interrupted Time Series Analysis. Mayo Clin Proc 2021; 96:1135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hallway A, Vu J, Lee J, et al. Patient Satisfaction and Pain Control Using an Opioid-Sparing Postoperative Pathway. J Am Coll Surg 2019; 229:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoppe JA, Nelson LS, Perrone J, et al. Opioid Prescribing in a Cross Section of US Emergency Departments. Ann Emerg Med 2015; 66:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiner SG, Chou SC, Chang CY, et al. Prescription and Prescriber Specialty Characteristics of Initial Opioid Prescriptions Associated with Chronic Use. Pain Med 2020; 21:3669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med 2015; 175:608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiels CA, Habermann EB, Hooten WM, Jeffery MM. Chronic use of tramadol after acute pain episode: cohort study. BMJ 2019; 365:l1849.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaheen PE, Walsh D, Lasheen W, et al. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manage 2009; 38:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaw, k, Fudin, J . Shaw K, Fudin J. Evaluation and comparison of online equianalgesic opioid dose conversion calculators. Pract Pain Manag 2013; 13:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rennick A, Atkinson T, Cimino NM, et al. Variability in Opioid Equivalence Calculations. Pain Med 2016; 17:892.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marco CA, Plewa MC, Buderer N, et al. Comparison of oxycodone and hydrocodone for the treatment of acute pain associated with fractures: a double-blind, randomized, controlled trial. Acad Emerg Med 2005; 12:282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slawson D. No Difference Between Oxycodone/Acetaminophen and Hydrocodone/Acetaminophen for Acute Extremity Pain. Am Fam Physician 2016; 93:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AK, Bijur PE, Holden L, Gallagher EJ. Comparative Analgesic Efficacy of Oxycodone/Acetaminophen Versus Hydrocodone/Acetaminophen for Short-term Pain Management in Adults Following ED Discharge. Acad Emerg Med 2015; 22:1254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zikovich S, Gunaseelan V, Englesbe M, et al. Association of Opioid Type With Opioid Consumption After Surgery. Ann Surg 2022; 276:e1070.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zacny JP, Lichtor SA. Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers. Psychopharmacology (Berl) 2008; 196:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wightman R, Perrone J, Portelli I, Nelson L. Likeability and abuse liability of commonly prescribed opioids. J Med Toxicol 2012; 8:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiner SG, Hendricks MA, El Ibrahimi S, et al. Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone. PLoS One 2022; 17:e0266561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howard R, Vu J, Lee J, et al. A Pathway for Developing Postoperative Opioid Prescribing Best Practices. Ann Surg 2020; 271:86.
          </a>
         </li>
         <li class="breakAll">
          Adult prescribing recommendations. Michigan OPEN. https://michigan-open.org/wp-content/uploads/2023/02/All-Adult-Prescribing-Recs.pdf.pdf (Accessed on May 29, 2023).
         </li>
         <li class="breakAll">
          FDA safety communication on discussing naloxone with all patients prescribed opioid pain relievers. US Food and Drug Administration. https://www.fda.gov/media/140360/download (Accessed on July 30, 2020).
         </li>
         <li class="breakAll">
          https://www.cdc.gov/drugoverdose/pdf/aha-patient-opioid-factsheet-a.pdf.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daoust R, Paquet J, Cournoyer A, et al. Side effects from opioids used for acute pain after emergency department discharge. Am J Emerg Med 2020; 38:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bates C, Laciak R, Southwick A, Bishoff J. Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice. J Urol 2011; 185:551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agarwal AK, Lee D, Ali Z, et al. Effect of Mailing an At-home Disposal Kit on Unused Opioid Disposal After Surgery: A Randomized Clinical Trial. JAMA Netw Open 2022; 5:e2210724.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brummett CM, Steiger R, Englesbe M, et al. Effect of an Activated Charcoal Bag on Disposal of Unused Opioids After an Outpatient Surgical Procedure: A Randomized Clinical Trial. JAMA Surg 2019; 154:558.
          </a>
         </li>
         <li class="breakAll">
          FDA Moves Forward with Mail-back Envelopes for Opioid Analgesics Dispensed in Outpatient Settings. US Food and Drug Administration, 2023. https://www.fda.gov/news-events/press-announcements/fda-moves-forward-mail-back-envelopes-opioid-analgesics-dispensed-outpatient-settings (Accessed on November 06, 2023).
         </li>
         <li class="breakAll">
          https://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm#Flush_List.
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 108806 Version 41.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31059823" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Effectiveness of Prescription Monitoring Programs in Reducing Opioid Prescribing, Dispensing, and Use Outcomes: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27869630" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : A Prospective Evaluation of Opioid Utilization After Upper-Extremity Surgical Procedures: Identifying Consumption Patterns and Determining Prescribing Guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26818326" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The Use of Opioid Analgesics following Common Upper Extremity Surgical Procedures: A National, Population-Based Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22410178" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Opioid consumption following outpatient upper extremity surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15525613" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Thirty percent of patients have moderate to severe pain 24 hr after ambulatory surgery: a survey of 5,703 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27631771" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28267689" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : An Educational Intervention Decreases Opioid Prescribing After General Surgical Operations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23682368" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Opioid pain medication use after dermatologic surgery: a prospective observational study of 212 dermatologic surgery patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27663358" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Unused opioid analgesics and drug disposal following outpatient dental surgery: A randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31186154" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Racial and ethnic disparities in the management of acute pain in US emergency departments: Meta-analysis and systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27044069" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32797734" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33358232" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : A Randomized Trial Comparing the Efficacy of Five Oral Analgesics for Treatment of Acute Musculoskeletal Extremity Pain in the Emergency Department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32806991" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Nonopioid, Multimodal Analgesia as First-line Therapy After Otolaryngology Operations: Primer on Nonsteroidal Anti-inflammatory Drugs (NSAIDs).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14622700" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Time-contingent schedules for postoperative analgesia: a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24338830" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Ibuprofen and/or paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom teeth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27939729" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Nonsteroidal Anti-inflammatory Drugs for Managing Postoperative Endodontic Pain in Patients Who Present with Preoperative Pain: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20007794" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Combined acetaminophen and ibuprofen for pain relief after oral surgery in adults: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20142348" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20142348" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22786464" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Opioid epidemic in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28761945" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31237629" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Association Between Quantity of Opioids Prescribed After Surgery or Preoperative Opioid Use Education With Opioid Consumption.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28489999" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Opioid Prescribing by Emergency Physicians and Risk of Long-Term Use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32219431" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Patient-Reported Opioid Pill Consumption After an ED Visit: How Many Pills Are People Using?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26824844" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27071690" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Frequency of unsafe storage, use, and disposal practices of opioids among cancer patients presenting to the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22204885" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : How do emergency department patients store and dispose of opioids after discharge? A pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28594763" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Patterns of Opioid Prescription and Use After Cesarean Delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28594766" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Postdischarge Opioid Use After Cesarean Delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28697049" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Wide Variation and Overprescription of Opioids After Elective Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29189368" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Opioid Prescribing for the Treatment of Acute Pain in Children on Hospital Discharge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29499361" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Post-Discharge Opioid Prescribing and Use after Common Surgical Procedure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29746919" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Opioid Medication Use in the Surgical Patient: An Assessment of Prescribing Patterns and Use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30422239" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Association of Opioid Prescribing With Opioid Consumption After Surgery in Michigan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31483475" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Opioid Prescribing After Surgery in the United States, Canada, and Sweden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33502440" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Patient-Reported Outcomes After Opioid-Sparing Surgery Compared With Standard of Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31710680" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : A Multidisciplinary Patient-Specific Opioid Prescribing and Tapering Protocol Is Associated with a Decrease in Total Opioid Dose Prescribed for Six Weeks After Total Hip Arthroplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25542435" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The effect of an educational program on opioid prescription patterns in hand surgery: a quality improvement program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23374416" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : A performance improvement prescribing guideline reduces opioid prescriptions for emergency department dental pain patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33958051" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Long-term Success With Diminished Opioid Prescribing After Implementation of Standardized Postoperative Opioid Prescribing Guidelines: An Interrupted Time Series Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31154092" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Patient Satisfaction and Pain Control Using an Opioid-Sparing Postoperative Pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25952503" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Opioid Prescribing in a Cross Section of US Emergency Departments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33094313" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Prescription and Prescriber Specialty Characteristics of Initial Opioid Prescriptions Associated with Chronic Use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25686208" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31088782" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Chronic use of tramadol after acute pain episode: cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19735901" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Opioid equianalgesic tables: are they all equally dangerous?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Shaw K, Fudin J. Evaluation and comparison of online equianalgesic opioid dose conversion calculators
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26352991" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Variability in Opioid Equivalence Calculations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15805317" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Comparison of oxycodone and hydrocodone for the treatment of acute pain associated with fractures: a double-blind, randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26926980" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : No Difference Between Oxycodone/Acetaminophen and Hydrocodone/Acetaminophen for Acute Extremity Pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26479162" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Comparative Analgesic Efficacy of Oxycodone/Acetaminophen Versus Hydrocodone/Acetaminophen for Short-term Pain Management in Adults Following ED Discharge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33605582" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Association of Opioid Type With Opioid Consumption After Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17899018" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22992943" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Likeability and abuse liability of commonly prescribed opioids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35381052" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31478976" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : A Pathway for Developing Postoperative Opioid Prescribing Best Practices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31478976" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : A Pathway for Developing Postoperative Opioid Prescribing Best Practices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31478976" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : A Pathway for Developing Postoperative Opioid Prescribing Best Practices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31478976" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : A Pathway for Developing Postoperative Opioid Prescribing Best Practices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31182367" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Side effects from opioids used for acute pain after emergency department discharge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21168869" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35522286" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Effect of Mailing an At-home Disposal Kit on Unused Opioid Disposal After Surgery: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30916733" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Effect of an Activated Charcoal Bag on Disposal of Unused Opioids After an Outpatient Surgical Procedure: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
